WeedLife News Network

Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife News Network.

Cannabis and Schedule One drugs,

Subscribe to this list via RSS

“Father of cannabis research” calls for rescheduling CBD - Cannabis News

PUEBLO — If the United States stopped viewing CBD as an illegal substance, it would unlock the marijuana compound’s immense potential as medicine, the “father of cannabis research” said Saturday.

Continue reading
Tags:
Cannabis Legaliazation, CBD Oil, cannabidiol oil, Schedule 1 drug, CBD, WeedWorthy Finance News, WeedWorthy Medical Marijuana News, WeedWorthy Political News, Colorado State University, Weed Worthy Law & Crime News, WeedWorthy World News, WeedWorthy Science News, WeedWorthy US News, WeedWorthy Activism News, WeedWorthy Cannabis Industry News cannabis, Cannabidiol oils, Schedule 1, cannabidiol, cannabidiol and medicine, history of marijuana, Schedule 1 of the Controlled Substances Act, CBD pills, Israel marijuana research, Clinical cannabis research in Israel, Israel, medical cannabis in Israel, reschedule marijuana, US firms investing in Israel medical marijuana research, reclassifying marijuana from Schedule 1, CBD vs. THC, rescheduling marijuana, Raphael Mechoulam, WeedWorthy History News, medical benefits of CBD, advocates call for marijuana rescheduling, THC vs.CBD, Cannabis and Schedule One drugs, cannabis and medicine,

“Father of cannabis research” calls for rescheduling CBD - Cannabis News

Featured

PUEBLO — If the United States stopped viewing CBD as an illegal substance, it would unlock the marijuana compound’s immense potential as medicine, the “father of cannabis research” said Saturday.

Continue reading
Tags:
Cannabis Legaliazation, CBD Oil, cannabidiol oil, Schedule 1 drug, CBD, WeedWorthy Finance News, WeedWorthy Medical Marijuana News, WeedWorthy Political News, Colorado State University, Weed Worthy Law & Crime News, WeedWorthy World News, WeedWorthy Science News, WeedWorthy US News, WeedWorthy Activism News, WeedWorthy Cannabis Industry News cannabis, Cannabidiol oils, Schedule 1, cannabidiol, cannabidiol and medicine, history of marijuana, Schedule 1 of the Controlled Substances Act, CBD pills, Israel marijuana research, Clinical cannabis research in Israel, Israel, medical cannabis in Israel, reschedule marijuana, US firms investing in Israel medical marijuana research, reclassifying marijuana from Schedule 1, CBD vs. THC, rescheduling marijuana, Raphael Mechoulam, WeedWorthy History News, medical benefits of CBD, advocates call for marijuana rescheduling, THC vs.CBD, Cannabis and Schedule One drugs, cannabis and medicine,

North Carolina hemp commission considers joining lawsuit against DEA - Cannabis News

RALEIGH -  The state commission charged with fostering an industrial hemp industry in North Carolina is considering joining a lawsuit against a government agency that it agrees is making things difficult: the U.S. Drug Enforcement Administration.

Continue reading
Tags:
Cannabis Oil should be a Schedule II Drug in Iowa, Hemp, DEA, Hemp legalization, WeedWorthy Hemp News, WeedWorthy Political News, Hemp Research, Weed Worthy Law & Crime News, WeedWorthy US News, WeedWorthy Cannabis Industry News Industrial Hemp, hemp products, Industrial Hemp Farming Act, hemp farms, Hemp Health, hemp vs. marijuana, U.S. Drug Enforcement Administration, Schedule 1 of the Controlled Substances Act, hemp construction, hemp as a mainstream commodity, federal law, North Carolina, hemp and politics, hemp as a political issue, North Carolina and hemp legalization, North Carolina and hemp farming, states allowing hemp research, North Carolina and hemp processing, federal law and hemp, North Carolina politics, politics and hemp, DEA and hemp legalization, Cannabis and Schedule One drugs,

North Carolina hemp commission considers joining lawsuit against DEA - Cannabis News

RALEIGH -  The state commission charged with fostering an industrial hemp industry in North Carolina is considering joining a lawsuit against a government agency that it agrees is making things difficult: the U.S. Drug Enforcement Administration.

Continue reading
Tags:
Cannabis Oil should be a Schedule II Drug in Iowa, Hemp, DEA, Hemp legalization, WeedWorthy Hemp News, WeedWorthy Political News, Hemp Research, Weed Worthy Law & Crime News, WeedWorthy US News, WeedWorthy Cannabis Industry News Industrial Hemp, hemp products, Industrial Hemp Farming Act, hemp farms, Hemp Health, hemp vs. marijuana, U.S. Drug Enforcement Administration, Schedule 1 of the Controlled Substances Act, hemp construction, hemp as a mainstream commodity, federal law, North Carolina, hemp and politics, hemp as a political issue, North Carolina and hemp legalization, North Carolina and hemp farming, states allowing hemp research, North Carolina and hemp processing, federal law and hemp, North Carolina politics, politics and hemp, DEA and hemp legalization, Cannabis and Schedule One drugs,

Copyright 2013 - 2022. WeedLife.com is a division of MjLink.com, Inc..

To invest in the MjLink network, CLICK HERE.

To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6

By using this website, you agree and understand that, by law: You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!


WeedLife.com